A closely watched cardiovascular drug from Novartis failed in a pivotal study, the company said Friday, a major blow to the ...
After the failure of an experimental drug for Angelman syndrome, experts cautioned that there is still reason to think ...
In the months before killing her children, Lindsay Clancy repeatedly sought help for her deteriorating mental health.
An organ transplant first, new details on ADA conference controversy, and more health news from Morning Rounds ...
AI products from Cadence and Limbic are among four devices recently accepted into the FDA’s TEMPO pilot that will allow ...
Two recipients of gene-edited pig kidneys have successfully received human organs, a milestone in the wider effort to advance ...
On Feb. 24, 2025, the Food and Drug Administration did something it arguably should have done long ago: It removed the ...
Is CDC now applying different standards to state data depending on who governs the state or what political party won an ...
Experts agreed that the biggest threat to progress on overdose deaths is the looming Medicaid cuts. Researchers at Penn’s ...
Ionis Pharmaceuticals on Thursday received Food and Drug Administration approval for the first disease modifying therapy for ...
Today, a look at how some generative AI medical devices are getting on the market quickly. Plus: OpenEvidence’s new AI models ...
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. Eli Lilly said Tuesday it would buy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results